Prospective Observational Study to Monitor and Assess the Safety of Amvuttra® [Vutrisiran] in a Real-World Cohort of hATTR Amyloidosis Patients First published 22/01/2024 Last updated 07/05/2025 EU PAS number:EUPAS108904 Study Ongoing